264 related articles for article (PubMed ID: 2784064)
21. Characterization of leukemic cells in CD2/CD19 double positive acute lymphoblastic leukemia.
Manabe A; Mori T; Ebihara Y; Koyama T; Okuyama I; Hosoya R; Kaneko M; Ishimoto K; Nakahata T; Nakazawa S
Int J Hematol; 1998 Jan; 67(1):45-52. PubMed ID: 9594444
[TBL] [Abstract][Full Text] [Related]
22. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
23. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
[TBL] [Abstract][Full Text] [Related]
24. High-Grade Epstein-Barr Virus-Negative Biphenotypic Lymphoma with Expression of B- and T-Cell Markers and Leukemia Presentation: Case Report and Literature Review.
Kohla S; Ibrahim FA; Mudawi D; Akiki S; Soliman D; Al-Sabbagh A; Youssef RRH; Yassin MA
Case Rep Oncol; 2020; 13(3):1215-1226. PubMed ID: 33173488
[TBL] [Abstract][Full Text] [Related]
25. Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.
Uckun FM; Gaynon P; Sather H; Arthur D; Trigg M; Tubergen D; Nachman J; Steinherz P; Sensel MG; Reaman GR
Blood; 1997 Apr; 89(7):2488-93. PubMed ID: 9116293
[TBL] [Abstract][Full Text] [Related]
26. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report.
Ichinohasama R; Endoh K; Ishizawa K; Okuda M; Kameoka J; Meguro K; Myers J; Kadin ME; Mori S; Sawai T
Cancer; 1996 Jun; 77(12):2592-603. PubMed ID: 8640711
[TBL] [Abstract][Full Text] [Related]
27. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
28. Characterization of CD7+CD19+ lymphoid cells after Epstein-Barr virus transformation.
Panzer-Grümayer ER; Panzer S; Wolf M; Majdic O; Haas OA; Kersey JH
J Immunol; 1993 Jul; 151(1):92-9. PubMed ID: 7686950
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
[TBL] [Abstract][Full Text] [Related]
30. Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia.
Thiel E; Kranz BR; Raghavachar A; Bartram CR; Löffler H; Messerer D; Ganser A; Ludwig WD; Büchner T; Hoelzer D
Blood; 1989 Apr; 73(5):1247-58. PubMed ID: 2467704
[TBL] [Abstract][Full Text] [Related]
31. A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9;22)(q34;q11) established from a patient with acute leukemia.
Matsuo Y; Drexler HG; Takeuchi M; Orita K
Leuk Res; 1999 Aug; 23(8):731-40. PubMed ID: 10456671
[TBL] [Abstract][Full Text] [Related]
32. Phenotype, genotype and cytokine production in acute leukemia involving progenitors of dendritic Langerhans' cells.
Srivastava BI; Srivastava A; Srivastava MD
Leuk Res; 1994 Jul; 18(7):499-511. PubMed ID: 7912755
[TBL] [Abstract][Full Text] [Related]
33. Human recombination activating gene-1 in leukemia/lymphoma cells: expression depends on stage of lymphoid differentiation defined by phenotype and genotype.
Yoneda N; Tatsumi E; Kawano S; Matsuo Y; Minowada J; Yamaguchi N
Blood; 1993 Jul; 82(1):207-16. PubMed ID: 8391873
[TBL] [Abstract][Full Text] [Related]
34. [CD5+, CD7+, and CD19+ non-Hodgkin's lymphoma in a child].
Toyoda Y; Horikoshi Y; Tonouchi T; Mimaya J; Hamazaki M; Taniguchi S; Kawai S; Kawa-ha K; Yumura K; Kaneko Y
Rinsho Ketsueki; 1991 Feb; 32(2):137-41. PubMed ID: 1709216
[TBL] [Abstract][Full Text] [Related]
35. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
36. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient.
Kawano S; Tatsumi E; Yoneda N; Yamaguchi N; Goji J; Ito H; Nagai T; Nishikori M; Okamura A; Koiwai O
Hematol Oncol; 1995; 13(1):1-11. PubMed ID: 7538482
[TBL] [Abstract][Full Text] [Related]
37. Acute lymphoblastic leukemia with the phenotype of a putative B-cell/T-cell bipotential precursor.
Lau LG; Tan LK; Koay ES; Ee MH; Tan SH; Liu TC
Am J Hematol; 2004 Oct; 77(2):156-60. PubMed ID: 15389907
[TBL] [Abstract][Full Text] [Related]
38. Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses.
Schardt C; Ottmann OG; Hoelzer D; Ganser A
Leukemia; 1992 May; 6(5):370-4. PubMed ID: 1375695
[TBL] [Abstract][Full Text] [Related]
39. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
[TBL] [Abstract][Full Text] [Related]
40. Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells.
Gore SD; Kastan MB; Civin CI
Blood; 1991 Apr; 77(8):1681-90. PubMed ID: 2015396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
